Microwave Energy for HPV Tissue Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for human papillomavirus (HPV) infections, such as cryotherapy and laser surgery, are not satisfactory as they do not effectively treat the underlying infection, can leave the virus in a latent state, and pose risks of recurrence and infection transmission through smoke plumes, while existing heat-based treatments lack deep penetration and generate harmful byproducts.
Innovation Solution
The use of microwave energy to induce localized hyperthermia, which denatures HPV viral particles, stimulates the production of heat shock proteins, and inhibits PI3-Kinase activation, promoting an immune response and eliminating the virus through precise energy deposition, thereby overcoming the limitations of existing treatments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Volume of moving object
If microwave energy is used to treat HPV-infected tissue, then deep penetration and effective viral denaturation are achieved, but the risk of harmful smoke plume generation increases
Solution Approach 1:
The patent applies microwave energy at specific frequencies (2.45 GHz or 5.8 GHz) and controlled power levels to heat infected tissue to temperatures between 40-45°C, denaturing viral particles without causing high-energy vaporization that generates smoke plume. This parameter control resolves the contradiction by achieving deep penetration while avoiding harmful byproducts.
2Temperature
If heat-based treatments are used to elevate tissue temperature, then viral denaturation is achieved, but deep penetration of energy is limited
Solution Approach 1:
The patent replaces conventional mechanical or contact-based heating methods with microwave electromagnetic radiation, which can penetrate deep into tissue volumes. The microwave energy is absorbed by water molecules in the tissue, converting electromagnetic energy to thermal energy throughout the infected volume, achieving both deep penetration and effective temperature elevation for viral denaturation.
3Manufacturing precision
If ablation or removal of HPV-infected tissue is performed, then visible lesions are eliminated, but the underlying viral infection remains untreated
Solution Approach 1:
The patent extracts and eliminates the harmful viral component through selective denaturation. By heating the infected tissue to 40-45°C, the microwave energy denatures the capsid proteins and genetic material of HPV particles specifically within the infected cells, while preserving surrounding healthy tissue. This approach removes the viral threat without requiring excision of large tissue volumes.
4Productivity
If high energy vaporization is used to treat HPV lesions, then rapid tissue removal is achieved, but infection transmission through smoke plume occurs
Solution Approach 1:
The patent changes the energy delivery parameters from high-power instantaneous vaporization to controlled microwave heating at moderate power levels sustained over time. This achieves viral denaturation and tissue coagulation through prolonged exposure to 40-45°C temperatures, eliminating smoke plume generation while maintaining treatment efficacy and preventing viral aerosolization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Microwave energy effectively penetrates deep into HPV-infected tissues, denatures viral particles, and stimulates an immune response, potentially providing a rapid, reliable, and repeatable treatment for HPV infections without the risks associated with other methods.
Implementation Method 1
Microwave radiation can easily penetrate deeply within the epidermal layers to the dermis
Implementation Method 2
The deposition of energy and thus treatment efficacy using heat is significantly affected by the delivery modality chosen
Implementation Method 3
Heat denatures the virus by destroying the shell of the viral particles exposing the antigenic site within the viral structure
Implementation Method 4
Heat shock proteins are a class of functionally related proteins whose expression is increased when cells are exposed to elevated temperatures or other stress
Data Source
AI summary
The invention provides methods and apparatus for the treatment of dermatological conditions, including, for example, viral infections, microbial infections, cancers, dermatological conditions and particularly infections of the skin caused by human papillomavirus (HPV).